Investor Regents Of The University Of California
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Regents Of The University Of California . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-05-12 13G/A 43,624,472
2025-04-11 13G/A 0
2025-01-31 13G/A 19,762,141
2025-01-31 13G/A 25,239,104 25,239,104
2025-01-28 13G SRZN / Surrozen, Inc. 138,764 133,207
2025-01-28 13G/A 4,867,773
2025-01-28 13G/A 302,775,462
2025-01-06 13G 18,195,051
2024-01-24 13G/A SRZN / Surrozen, Inc. 138,764
2024-01-24 13G/A 14,476,157
2024-01-24 13G/A 4,286,424
2024-01-24 13G/A US691205AG35 / Owl Rock Technology Finance Corp 25,239,104 25,239,104
2024-01-24 13G 302,775,462
2024-01-24 13G/A OBDC / Blue Owl Capital Corporation 27,024,369 17,499,887
2023-07-03 13G 2,338,057
2023-02-02 13G/A 12,031,404
2023-02-02 13G/A OBDC / Blue Owl Capital Corporation 32,157,815 27,024,369
2023-02-02 13G/A SRZN / Surrozen, Inc. 2,081,453 2,081,453
2023-02-02 13G/A US691205AG35 / Owl Rock Technology Finance Corp 25,239,104 25,239,104
2022-10-28 13G US691205AG35 / Owl Rock Technology Finance Corp 25,239,104
2022-10-28 13G 4,664,139
2022-01-27 13G OBDC / Blue Owl Capital Corporation 42,690,843 32,157,815
2022-01-27 13G/A SRZN / Surrozen, Inc. 2,081,453
2021-02-01 13G US2103731061 / Constellation Pharmaceuticals Inc 1,747,406 737,406
2021-02-01 13G RAPT / RAPT Therapeutics, Inc. 1,342,237 1,122,237
2021-02-01 13G ORCC / Owl Rock Capital Corp 42,972,171 42,690,843
2020-02-24 13G RAPT / RAPT Therapeutics, Inc. 1,342,237
2020-02-14 13G US2103731061 / Constellation Pharmaceuticals Inc 2,297,406 1,747,406
2020-02-14 13G ORCC / Owl Rock Capital Corp 20,271,511 42,972,171
2019-01-31 13G/A ORCC / Owl Rock Capital Corp 20,271,511
2018-07-25 13G US2103731061 / Constellation Pharmaceuticals Inc 2,297,406
2018-07-02 13G/A ORCC / Owl Rock Capital Corp 17,738,468
2017-06-12 13G/A ORCC / Owl Rock Capital Corp 14,856,319
2017-04-19 13G/A ORCC / Owl Rock Capital Corp 10,620,015
2017-01-04 13G ORCC / Owl Rock Capital Corp 6,120,015